Workers strike at Merck injectable drug plant in Goa, India over wages

By Gareth Macdonald

- Last updated on GMT

Related tags Pharmacology Trade union

Merck site in Ponda, Goa (image source Merck KGaA)
Merck site in Ponda, Goa (image source Merck KGaA)
Workers at a Merck KGaA injectable drug and soft gel capsules plant in Goa, India have gone on strike over a wages dispute.

The German firm announced the industrial action in a filing on the Bombay Stock Exchange filing (BSE) on Tuesday, explaining that employees at the Ponda site downed tools after talks with Union representative broke down.

Merck said: “Management is striving to convince the union to resume work and resume negotiations​.”

The firm also said it has implemented “continuity plans to maintain stable supply to the market​” and predicted the strike will not impact the availability of products.

Drugs and chemicals

The Ponda plant makes pharmaceuticals in a variety of dosage forms, primarily soft gel capsules and injectables.

It also produces chemicals used by the drug industry, including dehydrated culture media used in quality control operations.

According to Merck, the facility also produces the essential oil ingredient guaiazulene, the vitamin B deficiency treatment Thiamine Disulphide, the supplement vitamin E and the chemical stabilizer Oxynex ST, which is used in the cosmetics sector.

Around 300 people are employed at the facility.

Merck declined to comment further when contacted by in-Pharmatechnologist.com.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...